• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞-巨噬细胞融合细胞作为癌症的液体生物标志物和肿瘤增强剂。

Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.

机构信息

Department of Surgery, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65212, USA.

Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA.

出版信息

Int J Mol Sci. 2020 Mar 9;21(5):1872. doi: 10.3390/ijms21051872.

DOI:10.3390/ijms21051872
PMID:32182935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7084898/
Abstract

Although molecular mechanisms driving tumor progression have been extensively studied, the biological nature of the various populations of circulating tumor cells (CTCs) within the blood is still not well understood. Tumor cell fusion with immune cells is a longstanding hypothesis that has caught more attention in recent times. Specifically, fusion of tumor cells with macrophages might lead to the development of metastasis by acquiring features such as genetic and epigenetic heterogeneity, chemotherapeutic resistance, and immune tolerance. In addition to the traditional FDA-approved definition of a CTC (CD45-, EpCAM+, cytokeratins 8+, 18+ or 19+, with a DAPI+ nucleus), an additional circulating cell population has been identified as being potential fusions cells, characterized by distinct, large, polymorphonuclear cancer-associated cells with a dual epithelial and macrophage/myeloid phenotype. Artificial fusion of tumor cells with macrophages leads to migratory, invasive, and metastatic phenotypes. Further studies might investigate whether these have a potential impact on the immune response towards the cancer. In this review, the background, evidence, and potential relevance of tumor cell fusions with macrophages is discussed, along with the potential role of intercellular connections in their formation. Such fusion cells could be a key component in cancer metastasis, and therefore, evolve as a diagnostic and therapeutic target in cancer precision medicine.

摘要

尽管已经广泛研究了推动肿瘤进展的分子机制,但血液中循环肿瘤细胞(CTC)的各种群体的生物学性质仍未得到很好的理解。肿瘤细胞与免疫细胞融合是一个由来已久的假说,最近引起了更多的关注。具体来说,肿瘤细胞与巨噬细胞融合可能会通过获得遗传和表观遗传异质性、化疗耐药性和免疫耐受性等特征,导致转移的发展。除了传统的 FDA 批准的 CTC(CD45-,EpCAM+,细胞角蛋白 8+、18+或 19+,具有 DAPI+核)定义外,还鉴定出另一种循环细胞群体作为潜在的融合细胞,其特征是具有独特的、大的、多形核的癌相关细胞,具有上皮和巨噬细胞/髓样表型的双重表型。肿瘤细胞与巨噬细胞的人工融合导致迁移、侵袭和转移表型。进一步的研究可能会探讨这些细胞是否对癌症的免疫反应产生潜在影响。在这篇综述中,讨论了肿瘤细胞与巨噬细胞融合的背景、证据和潜在相关性,以及细胞间连接在其形成中的潜在作用。这些融合细胞可能是癌症转移的关键组成部分,因此作为癌症精准医学的诊断和治疗靶点不断发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/8ab7ddc1b964/ijms-21-01872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/2518d223b554/ijms-21-01872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/cc6cea999058/ijms-21-01872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/8ab7ddc1b964/ijms-21-01872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/2518d223b554/ijms-21-01872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/cc6cea999058/ijms-21-01872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b812/7084898/8ab7ddc1b964/ijms-21-01872-g003.jpg

相似文献

1
Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.肿瘤细胞-巨噬细胞融合细胞作为癌症的液体生物标志物和肿瘤增强剂。
Int J Mol Sci. 2020 Mar 9;21(5):1872. doi: 10.3390/ijms21051872.
2
Clinical and biological significance of circulating tumor cells in cancer.循环肿瘤细胞在癌症中的临床及生物学意义
Mol Oncol. 2016 Mar;10(3):408-17. doi: 10.1016/j.molonc.2016.01.010. Epub 2016 Feb 10.
3
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.转移性乳腺癌患者的血液中存在异质性非典型细胞群体。
Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.
4
The Fate of Fusions.融合的命运。
Cells. 2018 Dec 29;8(1):13. doi: 10.3390/cells8010013.
5
Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.循环肿瘤细胞与播散肿瘤细胞:动态中的诊断工具与治疗靶点
Oncotarget. 2017 Jan 3;8(1):1884-1912. doi: 10.18632/oncotarget.12242.
6
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.癌细胞与肿瘤相关巨噬细胞之间的串扰对于间质循环肿瘤细胞介导的结直肠癌转移是必需的。
Mol Cancer. 2019 Mar 30;18(1):64. doi: 10.1186/s12943-019-0976-4.
7
Tracking cancer progression: from circulating tumor cells to metastasis.追踪癌症进展:从循环肿瘤细胞到转移。
Genome Med. 2020 Mar 19;12(1):31. doi: 10.1186/s13073-020-00728-3.
8
Phenotype of circulating tumor cell: face-off between epithelial and mesenchymal masks.循环肿瘤细胞的表型:上皮与间充质特征的对峙
Tumour Biol. 2016 May;37(5):5663-74. doi: 10.1007/s13277-016-4796-5. Epub 2016 Jan 13.
9
Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.逃亡者:转移性疾病中的循环肿瘤细胞(CTCs)。
Cancer Metastasis Rev. 2019 Jun;38(1-2):297-305. doi: 10.1007/s10555-019-09795-4.
10
Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.循环肿瘤细胞(CTCs)在转移性乳腺癌中的异质性:不同需求的不同方法。
Adv Exp Med Biol. 2020;1220:81-91. doi: 10.1007/978-3-030-35805-1_6.

引用本文的文献

1
Unveiling the dual role of circulating tumor cells in colorectal cancer immunotherapy: a comprehensive review of biomarker utility and immune microenvironment crosstalk.揭示循环肿瘤细胞在结直肠癌免疫治疗中的双重作用:生物标志物效用与免疫微环境相互作用的全面综述
Front Immunol. 2025 Jun 6;16:1591359. doi: 10.3389/fimmu.2025.1591359. eCollection 2025.
2
Liquiritin improves macrophage degradation of engulfed tumour cells by promoting the formation of phagolysosomes via NOX2/gp91phox.甘草苷通过NOX2/gp91phox促进吞噬溶酶体的形成,从而改善巨噬细胞对吞噬的肿瘤细胞的降解。
J Pharm Anal. 2025 May;15(5):101093. doi: 10.1016/j.jpha.2024.101093. Epub 2024 Aug 28.
3

本文引用的文献

1
Macrophages enhance 3D invasion in a breast cancer cell line by induction of tumor cell tunneling nanotubes.巨噬细胞通过诱导肿瘤细胞形成隧道纳米管增强乳腺癌细胞系的三维浸润。
Cancer Rep (Hoboken). 2019 Dec;2(6):e1213. doi: 10.1002/cnr2.1213. Epub 2019 Aug 28.
2
Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.巨噬细胞融合通过激活上皮-间充质转化和 Wnt/β-连环蛋白信号通路促进乳腺癌细胞增殖、迁移和侵袭。
Arch Biochem Biophys. 2019 Nov 15;676:108137. doi: 10.1016/j.abb.2019.108137. Epub 2019 Oct 9.
3
Circulating Tumor Microenvironment in Metastasis.
转移中的循环肿瘤微环境
Cancer Res. 2025 Apr 15;85(8):1354-1367. doi: 10.1158/0008-5472.CAN-24-1241.
4
Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.细胞融合作为转移的驱动因素:在癌症异质性时代重新评估一个古老的假说。
Front Immunol. 2025 Feb 4;16:1524781. doi: 10.3389/fimmu.2025.1524781. eCollection 2025.
5
Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications.揭示结直肠癌中循环肿瘤细胞的动态变化:从生物学到临床应用
Front Cell Dev Biol. 2024 Oct 30;12:1498032. doi: 10.3389/fcell.2024.1498032. eCollection 2024.
6
Targeting of TAMs: can we be more clever than cancer cells?靶向肿瘤相关巨噬细胞:我们能否比癌细胞更聪明?
Cell Mol Immunol. 2024 Dec;21(12):1376-1409. doi: 10.1038/s41423-024-01232-z. Epub 2024 Nov 8.
7
The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology.可溶性 CD163(sCD163)在人体生理学和病理生理学中的作用。
Cells. 2024 Oct 11;13(20):1679. doi: 10.3390/cells13201679.
8
Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma.循环肿瘤-免疫杂交细胞作为晚期肝内胆管癌预后生物标志物的探索性分析。
Int J Mol Sci. 2024 Aug 24;25(17):9198. doi: 10.3390/ijms25179198.
9
Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics.循环肿瘤细胞:病理、分子和功能特征。
Int J Mol Sci. 2024 Jul 27;25(15):8198. doi: 10.3390/ijms25158198.
10
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma.葡萄膜黑色素瘤中具有转移特性的肿瘤免疫杂交细胞的检测
Biomark Res. 2024 Jul 20;12(1):67. doi: 10.1186/s40364-024-00609-6.
Mechanisms of immunotherapy resistance: lessons from glioblastoma.
免疫疗法耐药机制:胶质母细胞瘤的启示。
Nat Immunol. 2019 Sep;20(9):1100-1109. doi: 10.1038/s41590-019-0433-y. Epub 2019 Jul 29.
4
PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer.循环肿瘤细胞的程序性死亡受体配体1(PD-L1)表达与上皮-间质转化和根治性切除的非小细胞肺癌患者的不良生存相关。
Cancers (Basel). 2019 Jun 11;11(6):806. doi: 10.3390/cancers11060806.
5
Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.癌细胞融合:攻克耐药性和转移性癌细胞的潜在靶点。
Drug Discov Today. 2019 Sep;24(9):1836-1844. doi: 10.1016/j.drudis.2019.05.024. Epub 2019 Jun 1.
6
Liquid biopsy and minimal residual disease - latest advances and implications for cure.液体活检与微小残留病灶——最新进展及其对治愈的影响。
Nat Rev Clin Oncol. 2019 Jul;16(7):409-424. doi: 10.1038/s41571-019-0187-3.
7
Leukocyte⁻Cancer Cell Fusion-Genesis of a Deadly Journey.白细胞-癌细胞融合——致命之旅的起源。
Cells. 2019 Feb 18;8(2):170. doi: 10.3390/cells8020170.
8
Cell Fusion in Human Cancer: The Dark Matter Hypothesis.细胞融合与人类癌症:暗物质假说。
Cells. 2019 Feb 7;8(2):132. doi: 10.3390/cells8020132.
9
Tunneling nanotubes, a novel mode of tumor cell-macrophage communication in tumor cell invasion.隧道纳米管:肿瘤细胞侵袭中肿瘤细胞-巨噬细胞通讯的新方式。
J Cell Sci. 2019 Feb 11;132(3):jcs223321. doi: 10.1242/jcs.223321.
10
The Fate of Fusions.融合的命运。
Cells. 2018 Dec 29;8(1):13. doi: 10.3390/cells8010013.